Company Filing History:
Years Active: 2005
Title: Innovations by Barbara Papadopoulu
Introduction
Barbara Papadopoulu is a notable inventor based in California, recognized for her contributions to the field of biotechnology. She has made significant strides in developing innovative solutions for treating infections caused by macrophage-infecting parasites.
Latest Patents
Barbara holds a patent for "Macrophage-infecting parasites expressing a granulocyte macrophage colony stimulated factor." This invention involves strains of Leishmania and other macrophage-infecting parasites that express the GM-CSF gene. These strains are designed to treat hosts infected by the parasite and protect them against diseases caused by such infections. The parasites are modified to reduce their ability to infect or survive in macrophages, making them attenuated. Additionally, at least one gene contributing to the virulence of the parasite may be functionally disabled. The attenuated strains can be administered to treat hosts infected by Leishmania or to confer protection against diseases caused by virulent strains, and they may also serve as diagnostic reagents.
Career Highlights
Barbara is currently associated with Aventis Pasteur Limited, where she continues to work on innovative solutions in the field of infectious diseases. Her research and inventions have the potential to significantly impact public health and improve treatment options for affected individuals.
Collaborations
Some of her notable coworkers include Marc Ouellette and Martin Olivier, who have collaborated with her on various projects related to her research and inventions.
Conclusion
Barbara Papadopoulu's work exemplifies the importance of innovation in addressing health challenges posed by infectious diseases. Her contributions through her patent and collaborations highlight her commitment to advancing medical science and improving patient outcomes.